BRANDOLINI, LUIGI
BRANDOLINI, LUIGI
Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy
2023-01-01 Cristiano, C; Giorgio, C; Cocchiaro, P; Boccella, S; Cesta, M C; Castelli, V; Liguori, F M; Cuozzo, M R; Brandolini, L; Russo, R; Allegretti, M
Emerging role of C5 complement pathway in peripheral neuropathies: Current treatments and future perspectives
2021-01-01 Giorgio, C.; Zippoli, M.; Cocchiaro, P.; Castelli, V.; Varrassi, G.; Aramini, A.; Allegretti, M.; Brandolini, L.; Cesta, M. C.
Cxcr1/2 inhibitor ladarixin ameliorates the insulin resistance of 3t3-l1 adipocytes by inhibiting inflammation and improving insulin signaling
2021-01-01 Castelli, V.; Brandolini, L.; D'Angelo, M.; Giorgio, C.; Alfonsetti, M.; Cocchiaro, P.; Lombardi, F.; Cimini, A.; Allegretti, M.
Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics
2020-01-01 Antonosante, A.; Brandolini, L.; D'Angelo, M.; Benedetti, E.; Castelli, V.; Maestro, M. D.; Luzzi, S.; Giordano, A.; Cimini, A.; Allegretti, M.
NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes
2020-01-01 Brandolini, L.; Antonosante, A.; Giorgio, C.; Bagnasco, M.; D'Angelo, M.; Castelli, V.; Benedetti, E.; Cimini, A.; Allegretti, M.
DF3016A induces increased BDNF transcription in ischemic neuroinflammation injury
2020-01-01 Grannonico, M; Brandolini, L; Giustino Varrassi, G; Sebastiani, P; Colanardi, A; Paladini, A; Piroli, A; Allegretti, M; Di Loreto, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy | 1-gen-2023 | Cristiano, C; Giorgio, C; Cocchiaro, P; Boccella, S; Cesta, M C; Castelli, V; Liguori, F M; Cuozzo, M R; Brandolini, L; Russo, R; Allegretti, M | |
| Emerging role of C5 complement pathway in peripheral neuropathies: Current treatments and future perspectives | 1-gen-2021 | Giorgio, C.; Zippoli, M.; Cocchiaro, P.; Castelli, V.; Varrassi, G.; Aramini, A.; Allegretti, M.; Brandolini, L.; Cesta, M. C. | |
| Cxcr1/2 inhibitor ladarixin ameliorates the insulin resistance of 3t3-l1 adipocytes by inhibiting inflammation and improving insulin signaling | 1-gen-2021 | Castelli, V.; Brandolini, L.; D'Angelo, M.; Giorgio, C.; Alfonsetti, M.; Cocchiaro, P.; Lombardi, F.; Cimini, A.; Allegretti, M. | |
| Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics | 1-gen-2020 | Antonosante, A.; Brandolini, L.; D'Angelo, M.; Benedetti, E.; Castelli, V.; Maestro, M. D.; Luzzi, S.; Giordano, A.; Cimini, A.; Allegretti, M. | |
| NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes | 1-gen-2020 | Brandolini, L.; Antonosante, A.; Giorgio, C.; Bagnasco, M.; D'Angelo, M.; Castelli, V.; Benedetti, E.; Cimini, A.; Allegretti, M. | |
| DF3016A induces increased BDNF transcription in ischemic neuroinflammation injury | 1-gen-2020 | Grannonico, M; Brandolini, L; Giustino Varrassi, G; Sebastiani, P; Colanardi, A; Paladini, A; Piroli, A; Allegretti, M; Di Loreto, S |